Member Info for 2cvguy

Ripley - there's a pretty much unanimous view on here that the trial patient should not be referred to by name (as a bare minimum). As I understand it, you always post using the same thread for your own purpose of grouping all your posts together ? Why not start a new thread called "Ripley's Thread", then nobody will object. It's as simple as that, and the sensible and decent thing to do.

I'm confused then, what's this RNS from 17th April 2015 ?
" Moditope® citrullinated peptides destroy tumours and extend survival.
Poster to be presented at American Association for Cancer Research Annual Meeting.
Scancell Holdings plc ('Scancell' or the 'Company'), the developer of novel immunotherapies for the treatment of cancer, today announces that a poster exemplifying the Company's Moditope® immunotherapy platform has been accepted for presentation at the American Association for Cancer Research Annual Meeting (AACR) in Philadelphia, Pennsylvania, 18-22 April 2015."
https://www.lse.co.uk/rns/SCLP/poster-on-moditope-to-be-presented-at-aacr-111jly8p3u3sj3v.html

Thanks, LTI. Not been keeping tabs on things as much as I perhaps should and imagined the order book was a bit bigger by now. It does add some weight to Colour's thoughts on the RNS, although I still think he may be over-analysing it (we hope !).

Clarifying RNS's is the sort of thing CC will do I believe, so i would think that anyone who wants to be certain could email the company.

OK, I think I see what you are getting at now, I do wonder if you are perhaps being a little pedantic though. On the other hand you might just be right, in which case mea culpa and I should know CC RNS's better by now !

Admittedly I don't know what the company's current order book is, but perhaps JC is referring to additional, future, meter installs with the same partner - hence the term "partner" and not "agreement". Of course, I could be being overly optimistic, but the RNS does still say they will provide hardware and services for the full 3 million.

Which bit are you reading Coulor ? I thought I'd missed something, but the RNS does say "CyanConnode WILL provide Omnimesh RF modules, Advanced Metering Infrastructure, Standards-Based Hardware, Omnimesh Head-End Software and associated components, Perpetual License, design, installation, implementation, integration, training and support & Maintenance Contract for 3 MILLION smart meters". (Caps are mine).
Maybe I'm misunderstanding what you are saying ...

Good to have the clarification that Covidity is not (yet) being shelved, which the interims RNS was rather ambigous about - i.e. "the Company does not intend to do further trials". Now we have: "decided not to take this vaccine forward IN HOUSE".

I like the bit about "broad reactivity against multiple COVID-19 variants".

So CC will not provide the smart meters themselves. Makes more sense.

You're probably right, Jake. Perhaps my expectations have been worn down over the years.

Short of an actual firm order, this RNS seems as good as it gets to me. "CyanConnode will provide 3 million smart meters". "Will" "3 million".

"monkey statue", not "momkey status" !

I think Hartlepool embraces the money hanger tale these days. They've got a momkey status by the harbour, and Hartlepool FC's mascot is H'Angus the Monkey. H'Angus was even elected mayor a couple of times, which I've only just learned.

Got a feeling in me water that we'll get trial updates this week ...

It was the same wording in December 21 for the January interims, WF. I guess it is just being cautious.

You're all doing a fantastic job to stirrup anticipation.

Very well thanks, LTI. You too I hope.
I've not been very active on these boards recently, especially this one, but at long last it seems like it is starting to get interesting here.

I'm really surprised nobody's come out with "Montecarlo or Bust" yet. Colour? LOL.

If this is our "not going up in a stright line", I can live with it.

I'm getting Bid of 24.825 for 100,000 (on HL). Indicative Bid still showing as 24. Strange.